All Companies
Ticker FOLD
This stock is no longer actively trading
You reached the page — here's exactly what FOLD is, and why it's out of scope for now.
What this ticker is
FOLD
Amicus Therapeutics, Inc.
NASDAQ
Healthcare
Biotechnology
United States
Mkt cap $4.5B
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vit…
Why we can't analyze it yet
This ticker is delisted or inactive, so its financial data is frozen or incomplete and we don't produce a live analysis for it — the figures would be stale. Here's what the ticker is and why it's out of scope.
Delvantic analyzes regular securities of single operating companies — one business with revenue, earnings and cash flows our valuation methods can assess bottom-up.
Reason code:
delisted